Oncology primary care clinics for comprehensive care of high-risk adolescent and young adult (AYA) cancer survivors.

A Alique Gabrielle Topalian (University of Cincinnati College of Medicine, Cincinnati, OH) M Melinda Butsch Kovacic (University of Cincinnati College of Allied Health Sciences, Cincinnati, OH) E Elizabeth Ann Shaughnessy (University of Cincinnati College of Medicine, Cincinnati, OH) M Melissa Erickson (University of Cincinnati College of Medicine, Cincinnati, OH)

Abstract

1641 Background: Adolescent and young adult (AYA) cancer survivors experience early development of chronic medical conditions compared to healthy peers. Due to their young age at diagnosis and living decades beyond treatment, they are also at higher risk for second primary malignancies (SPM) and late effects than older adult-onset cancer survivors. Primary care providers are responsible for most long-term care of survivors and many are unfamiliar with the effects of cancer treatment in younger populations. Oncology primary care providers are uniquely positioned to address increased needs of AYA patients because of their additional survivorship expertise. Methods: In 2020, the University of Cincinnati Cancer Center established an oncology primary care clinic. An accompanying clinical registry was developed to track patient outcomes longitudinally Electronic medical records of all patients seen between 1/2021 and 1/2025 (n = 901) were extracted and entered in REDCap. Records of AYA cancer survivors, defined as cancer diagnosis between the ages of 18-39, were queried and analyzed (9%, n = 85). Results: The patient population’s mean age was 36 yrs (range 20-74; std dev = 11.3). Hematologic cancers (37%) were most common followed by breast (13%) and brain (9%). Additionally, 14% were diagnosed with a SPM. Comorbid conditions were prevalent with 60% of patients having cardiovascular disease such as hypertension. Neurologic (46%), endocrine (44%), and psychologic (71%) co-morbidities were also common. Over half of patients were overweight/obese (68%) and many patients were former (19%) or current (7%) smokers. Eligible patients received their recommended cancer screening including breast (82%), colon (60%), and cervical (40%). Due to treatment exposures, 53% of patients were eligible for cardiomyopathy screening and 73% received recommended echocardiograms. A reduced ejection fraction was found in 26% of patients screened. Conclusions: Comprehensive primary care services and longitudinal monitoring are imperative in this high-risk population. Oncology primary care provides necessary survivorship-informed care and longitudinal monitoring for early onset comorbidities and SPMs. Tailored education and outreach efforts for providers and patients should address preventative health services needed in this high-risk population.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 1641-1641
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (4)

A

Alique Gabrielle Topalian

University of Cincinnati College of Medicine, Cincinnati, OH

M

Melinda Butsch Kovacic

University of Cincinnati College of Allied Health Sciences, Cincinnati, OH

E

Elizabeth Ann Shaughnessy

University of Cincinnati College of Medicine, Cincinnati, OH

M

Melissa Erickson

University of Cincinnati College of Medicine, Cincinnati, OH